iRhythm Technologies, Inc. (IRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/12/26
iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/12/26
iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 12/29/25
iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 TranscriptSeeking Alpha • 12/03/25
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTCBusiness Wire • 11/13/25
iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025GlobeNewsWire • 11/11/25
iRhythm Technologies (IRTC) Reports Q3 Loss, Beats Revenue EstimatesZacks Investment Research • 10/30/25
iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025GlobeNewsWire • 10/16/25
IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTCGlobeNewsWire • 09/18/25
IRhythm Technologies, Inc. (IRTC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/09/25
IRTC Unveils Positive AMALFI Trial Data Showing Higher AF DetectionZacks Investment Research • 09/02/25
AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM ServiceGlobeNewsWire • 08/29/25
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical SuperiorityGlobeNewsWire • 08/18/25
iRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 07/31/25